The U.S. bone grafts and substitutes market is entering a phase of durable, mid-single-digit growth. Valued at USD 948.1 million in 2023, the market is projected to expand at a CAGR of 5.6% from 2024 to 2030, pushing total revenue to approximately USD 1.4 billion by the end of the decade. That trajectory reflects a market that isn't booming overnight, but is compounding steadily on the back of...